FTRP Field Trip Health Ltd.

Field Trip is leading the medical and scientific re-emergence of psychedelics and psychedelic-enhanced therapies. Through Field Trip Health's intentionally-designed, technology-empowered clinics providing psychedelic therapies, Field Trip Digital's apps and resources scaling our protocols globally, and Field Trip Discovery, our drug development division developing the next generation of psychedelic molecules, we help people through an integrated, evidence-based approach to healing and thriving.

Note: This is not a U.S. company, but they cross-list their shares on a U.S. stock exchange - see the related symbol CT:FTRP.

$4.58
As of 09/16/2021     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Medical Care Facilities
Index country:  Canada
Country of incorporation:  
IPO date:  10/06/2020
Outstanding shares:  57,701,289
Average volume:  112,396
Market cap:   $264,848,917
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      40-F
CUSIP:    
ISIN:        
Sedol:      
Valuation   (See tab for details)
PE ratio:   -8.08
PB ratio:   2.57
PS ratio:   146.76
Return on equity:   -31.78%
Net income %:   -1,811.34%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy